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Abstract
Background: Work on pharmacovigilance systems using texts from PubMed and Twitter typically target at different elements
and use different annotation guidelines resulting in a scenario where there is no comparable set of documents from both Twitter
and PubMed annotated in the same manner.
Objective: This study aimed to provide a comparable corpus of texts from PubMed and Twitter that can be used to study drug
reports from these two sources of information, allowing researchers in the area of pharmacovigilance using natural language
processing (NLP) to perform experiments to better understand the similarities and differences between drug reports in Twitter
and PubMed.
Methods: We produced a corpus comprising 1000 tweets and 1000 PubMed sentences selected using the same strategy and
annotated at entity level by the same experts (pharmacists) using the same set of guidelines.
Results: The resulting corpus, annotated by two pharmacists, comprises semantically correct annotations for a set of drugs,
diseases, and symptoms. This corpus contains the annotations for 3144 entities, 2749 relations, and 5003 attributes.
Conclusions: We present a corpus that is unique in its characteristics as this is the first corpus for pharmacovigilance curated
from Twitter messages and PubMed sentences using the same data selection and annotation strategies. We believe this corpus
will be of particular interest for researchers willing to compare results from pharmacovigilance systems (eg, classifiers and named
entity recognition systems) when using data from Twitter and from PubMed. We hope that given the comprehensive set of drug
names and the annotated entities and relations, this corpus becomes a standard resource to compare results from different
pharmacovigilance studies in the area of NLP.
(JMIR Public Health Surveill 2017;3(2):e24)   doi:10.2196/publichealth.6396
KEYWORDS
Twitter; PubMed; corpus; pharmacovigilance; natural language processing; text mining; annotation
Introduction
Corpora annotated for adverse drug events are becoming
important in order to train computers to automatically build
adverse drug reaction profiles for post marketing surveillance.
Researchers are typically interested in understanding the
accuracy of their systems [1-8], whereas at the same time only
a limited number of corpora exist [9-12].
Pharmacovigilance (drug safety) systems using texts obtained
from the scientific literature have received attention for many
years [1,6-8] and since recently researchers started exploring
Twitter and other nonscientific texts where patients describe
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diseases and symptoms [2-4]. However, there is currently no
way to systematically compare systems performance across text
types.
In this paper we provide a benchmark corpus composed of
semantically correct annotations that can be used in natural
language processing (NLP) studies and show our approach to
produce a comparable corpora using texts from Twitter and
PubMed, explaining our strategy for controlling external
variables that may affect the sample.
Social media texts are known for containing a high proportion
of ungrammatical constructions out of vocabulary words,
abbreviations, and metaphoric usage [13], whereas scientific
texts are known for the use of specialized vocabulary and
well-formed sentences. Secondary key factors involved in a
direct comparison are the data selection methods and the
topicality [14].
Existing corpora from PubMed and Twitter cannot be directly
compared and the goal of this research is to produce a
comparable corpus of drug-related sentences targeting at the
same set of drugs.
To date, most of the curated corpora for pharmacovigilance
come from scientific formal texts obtained from PubMed
[15,16], although datasets curated from other scientific
resources, such as the Khresmoi project [17], are also available
[18].
Since a few years ago, corpora obtained from social media texts
started emerging. At first, researchers focused on blogs and
forums [19,20] and then on Twitter’s data [3,21,22] due to the
high volume of the information it provides, with 310 million
monthly active users [23] generating over 500 million tweets
per day [24] and also motivated by its “realtime” information,
allowing health researchers to potentially investigate and identify
new adverse drug event (ADE) types faster than traditional
methods such as physician reports.
Researchers have assessed the number of scientific works in
PubMed where Twitter data was used [25], finding that the
interest in Twitter is growing within the medical domain.
Pharmacovigilance sees Twitter as a useful resource in different
areas. Messages found in Twitter tweets can help researchers
to understand temporal patterns on the drugs usage [26], can
provide a good resource for obtaining first-hand experience
reports on the drugs use [21], and can be useful in the early
detection of prescription medication abuse [27] and adverse
events [3,28].
Recent examples where researchers used Twitter to build
different corpora are: (1) the corpus built to understand patient
experiences at health care facilities [29], (2) the corpus built to
measure the public interest and concerns about different diseases
[30], and (3) the corpus used to assess the positive or negative
attitude toward specific treatments [31]. Although texts written
in English have been used very frequently in NLP for
pharmacovigilance, texts in Spanish extracted from social media
[32] and French clinical texts [33] have been also used.
The work on Twitter and PubMed is an ongoing effort resulting
in promising NLP studies on the automatic recognition of
medications and adverse events [34,35] and also on the medical
question answering [36,37]. By releasing our corpus, we hope
other researchers can benefit from it and continue advancing in
this area.
Methods
Data Selection
For our study, we selected a set of 30 different drugs used in
other pharmacovigilance studies [3,5,21,38,39]. Including these
drugs allowed us to cover different interests in the research
community and also allowed us to account for drugs used to
treat very different conditions such as cancer [3], attention deficit
disorders [5,21,39], schizophrenia [3,38], or depression
[5,21,38,39].
We employed Twitter’s application programming interface
(API) to download messages mentioning any of those drug
names or their synonyms by running our script from September
7, 2015 to October 10, 2015, obtaining 165,489 tweets. In the
case of PubMed, we obtained the list of articles about those
drugs by using EuropePMC RESTful Web Services [40], issuing
our query on October 21, 2015 to search for texts containing
the same keywords that we used when collecting tweets. Once
we had the list of PubMed articles, we processed them to extract
the sentences containing the drug mentions obtaining 29,435
sentences.
From these sentences, we removed all non-ASCII (American
standard code for information interchange) characters (eg,
emojis), replaced all user name mentions with “__username__,”
all email addresses with “__email__,” and all numbers with
“__number__.” We also reduced characters elongation by
removing the repetition of a character after the second
occurrence eg, “greeeeeeat” would become “greeat”), and
lowercased all sentences.
Using the preprocessed sentences and aiming at maximizing
the informativeness and the variability of the texts, we limited
the number of tweets any user could contribute to 5 and
discarded sentences shorter than 20 characters in length,
retweets, tweets not written in English, sentences containing
keywords related to marketing campaigns (for this we created
a list built heuristically using 5 words commonly related to
marketing campaigns: “buy,” “cheap,” “online,” “pharmacy,”
“price”), and also discarded sentences including URLs.
To discard possibly duplicated sentences, we stored 40-character
long substrings appearing in the chosen sentences and searched
for these substrings in the candidate sentences keeping only the
messages not containing them. For each chosen sentence, we
only stored one substring composed of a maximum of 40
characters (less for sentences shorter than 60 characters in
length), extracted from the character in position 20th onwards.
This decision was driven by the observation that there were a
number of tweets conveying the same information using minor
rewording for the sentences, making them unique. In this
scenario, discarding the sentences replicating information
contributes to increase the information diversity.
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This strategy aims at further increasing the variability of the
texts by filtering out similar messages, and in case of selecting
the message “Lisinopril is used for treating high blood pressure
alone or with other medicines. Other names for this medication.
Acecomb, Acelisino” by extracting the characters in position
20 to position 40 (“or treating high blood pressure alone or”),
we are able to discard possible duplicated sentences such as
“lisinopril and hctz 20 mg 25 mg—national institutes
of...lisinopril is used for treating high blood pressure alone or
with other,” and similarly the system is also able to discard the
sentence “Jun 29, 2015...Active Ingredient: Lisinopril. Prinivil
is used for treating high blood pressure alone or with other
medicines. Other.” This strategy also showed its usefulness
when applied to PubMed sentences as observed in the substring
“mg oral granules are bioequivalent to s” appearing twice in the
same article, first in the abstract (“Sandoz montelukast 4 mg
oral granules are bioequivalent to Singulair 4 mg mini oral
granules, with a similar safety profile . ”), and also in the
discussion (“The current study has clearly demonstrated that
Sandoz montelukast 4 mg oral granules are bioequivalent to
Singulair mini 4 mg oral granules in terms of the rate and extent
of absorption of each formulation . ”), thereby showing that this
method can help in reducing the amount of duplicated
information.
Out of the resulting sentences, we automatically selected 6000
sentences each for both Twitter and PubMed, which we extracted
in a round-robin fashion aiming at a balanced sample of the
drug mentions.
We were interested in finding which sentences would be of
interest, for which we divided the main task in two phases.
During the first phase, both annotators were requested to perform
a sentence level annotation to extract 1000 positive sentences
(ie, the sentences mentioning drugs, symptoms, and diseases
related to the drug effects in humans) out of the 6000 sentences.
In the second phase, the annotators would use the annotation
guidelines to identify the entities and relations appearing in the
1000 sentences identified during the first phase.
The aim of this pipeline is to filter the most informative
sentences, discarding those sentences that are prone to include
information that is not of high relevance for pharmacovigilance
studies.
Figure 1 shows the pipeline used to filter, classify, and annotate
the sentences. Despite the difference in the initial number of
raw sentences we had from Twitter and PubMed (165,489 tweets
and 29,435 PubMed sentences), the steps described in the figure
provided the same number of sentences at the end of each
process.
Figure 1. Annotation pipeline. The initial number of raw sentences differed between twitter (165,489 tweets) and PubMed (29,435 sentences).
Selecting the Annotators
We identified 6 people who were willing to contribute to the
task and prepared a test to identify the best candidates. We
provided them with 20 sentences from Twitter and 20 sentences
from PubMed obtained from the 6000 sentences we had
previously filtered, and their task was to identify the sentences
containing a mention to a drug and a related disease or symptom.
The 6 candidate annotators had different backgrounds: one of
them was a native English speaker, three of them were
pharmacists, and the last two of them were active social media
users. Except for the native English speaker, the rest of the
annotators were native Spanish speakers able to read English
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texts. Although the pharmacists are not referred to as “active
social media users,” the three of them were millennials who
used social media networks to some extent.
Annotation
The annotation guidelines were prepared after reviewing existing
guidelines used in other pharmacovigilance projects. In the ADE
corpus guidelines [10], the researchers annotated the drugs,
adverse effects, dosages, and the existing relations between
these elements, whereas in the meta-knowledge annotation of
bio-events [11], the researchers followed a slightly different
approach and focused on different “dimensions” of the
biomedical events. Those dimensions can be thought as
attributes of those events as these dimensions are the knowledge
type, the level of certainty, the polarity, the manner, and the
source of the annotated event.
Similarly, to the annotation of the ADE corpus, the Arizona
disease corpus (AZDC) annotation guidelines [41] focused on
the annotation of the diseases, also covering syndromes,
illnesses, and disorders. Another document consulted to prepare
the first draft of our annotation guidelines was the shared
annotated resources (ShARe) or Conference and Labs of the
Evaluation Forum (CLEF) eHealth 2013 shared task I [12],
where the authors annotated disorders using the concept unique
identifier (CUI), also clarifying that a disorder is understood as
“any span of text that can be mapped to a concept in the
SNOMED-CT terminology, which belongs to the Disorder
semantic group,” clarifying that the Disorder semantic group
should include “congenital abnormalities,” “diseases or
syndromes,” and “signs and symptoms” among others.
Other supporting document used to prepare the annotation
guidelines was the annotation guidelines for the drug-drug
interaction (DDI) corpus [9], where the authors focused on the
annotation of a number of entities such as drugs approved for
human use, brand names for approved drugs, drugs that have
not been approved for human use, and different drug groups.
These guidelines also describe the annotation for different types
of relations existing between the entities: “advice,” “effect,”
“mechanism,” or “other.”
The details on the resulting corpora produced by the researchers
using the aforementioned annotation guidelines can be found
in Table 1.
Table 1. Details on the resulting corpora produced by the researchers who used the guidelines we reviewed.
ShARed or CLEFe
eHealth 2013 Task I
AZDCccorpusADEbcorpusDDIacorpusCorpus name
DisordersDiseasesDrug, adverse effects, dosagesPharmacological substancesAnnotated entities
--Drug-adverse effect, drug-dosageDrug-drug interactionsAnnotated relations
Clinical notesPubMed abstractsMEDLINEDrugBank and MEDLINETexts origin
200794 (2775 sentences)29721025Number of documents
22 (after automatic annotation)3 (after automatic annotation)2Number of annotators
Upon requestFreeFreeFree use for academic researchAvailability
KnowtatorIn-house toolKnowtatorBratAnnotation Tool
aDDI: drug-drug interaction.
bADE: adverse drug event.
cAZDC: Arizona disease corpus.
dShARe: shared annotated resources.
eCLEF: Conference and Labs of the Evaluation Forum.
As shown in Table 1, for the annotation of these corpora,
researchers have used tools such as Brat [42] and Knowtator
[43]. In our case, Brat tool was chosen after taking into account
that it is a Web-based annotation tool that eases key elements
of the annotation process.
The use of the mentioned guidelines eased the task of generating
the first draft of our guidelines, and allowed us to identify which
were the entities, relations, and attributes to be annotated. This
first draft was then used by three external annotators with a
background in computer science who annotated a small set of
PubMed and Twitter sentences. During that first annotation
period, we had daily meetings after each annotation session and
refined the guidelines upon the discrepancies we found and the
questions raised by the annotators. Those comments and
question in combination with the information we found in the
existing guidelines was used to provide the annotators with an
updated version of the guidelines for the next annotation session.
After 2 weeks and 6 annotation sessions, the number of
discrepancies was reduced to a minimum and no more questions
were raised, leading us to agree on freezing the guidelines so
that these would be used as they were.
The final version of the guidelines used in our study includes
three different entities: (1) Drug: any of the marketed medicines
that appears in the SIDER database [44], which is also listed in
the closed set of drugs we provided to the annotators, (2)
symptom: any sign or symptom contained in MedDRA [45]
ontology, and (3) disease: any disease contained in MedDRA
ontology.
The use of SIDER, which contains information on marketed
medicines extracted from public documents and package inserts,
and MedDRA, a medical terminology dictionary aimed at easing
the annotators’ task by providing them two well-known
resources to provide the annotated entities with a standardized
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concept identifier. We believe the fact that those resources are
of common use in the research community, and combined with
the current trend to map concepts in these databases to concepts
in other resources [46,47], provides an important element toward
TwiMed corpus reuse.
• Polarity: Used to indicate whether the entity was negated
or not. The negation had to be a linguistic negation (“not,”
“don’t”...).
• Person: Used to indicate whether the entity was affecting
the “1st,” “2nd,” “3rd” person, or whether there was no
information. This attribute was based on the original sender.
• Modality: Used to indicate whether the entity was stated in
an “actual,” “hedged,” “hypothetical,” or “generic” way.
• Exemplification: Used to indicate whether the entity was
presented using an example or a description. This attribute
was only to be used when the entity was presented through
an exemplification.
• Duration: Used to indicate whether the entity’s lasting span
was “intermittent,” “regular,” “irregular,” or not stated. In
the case of drugs, this attribute referred to the time span
when the drug had been taken.
• Severity: Used to indicate whether the seriousness of an
entity was “mild,” “severe,” or not stated. This was the only
attribute that did not apply to drugs.
• Status: Used to indicate whether the duration of the entity
was “complete,” “continuing,” or not stated. In the case of
drugs, this attribute referred to the time span when the drug
was perceived as having effect.
• Sentiment: Used to indicate whether the entity was
perceived as “positive,” “negative,” or “neutral.”
• Entity identifier: Used to indicate the CUI for that entity.
This was the only attribute that had to be filled for all
annotated entities. For this attribute we provided a list of
allowed values, and used the value “−1” (not found) for
entities whose CUI would not be present in the list.
The list of attributes was decided based on the combination of
elements noticed to be annotated in pharmacovigilance studies
using formal texts (eg, “duration” or “modality”), as well as in
pharmacovigilance studies using informal texts (eg, “polarity”
or “sentiment”).
• Reason-to-use: Used to represent the relation appearing
when a symptom or disease leads to the use of some drug.
• Outcome-positive: Used to represent the relation between
a drug, and an expected or unexpected symptom or disease
appearing after the drug consumption. The outcome had to
be positive.
• Outcome-negative: Used to represent the relation between
a drug, and an expected or unexpected symptom or disease
appearing after the drug consumption. The outcome had to
be negative.
These elements are further explained in the annotations
guidelines that are shared in the Multimedia Appendix 2.
Once the guidelines were ready and the annotators were chosen,
we preprocessed the sentences before presenting them to the
annotators by replacing the existing emojis with a string
describing each character, and discarded other non-ASCII
characters. We also decided not to lower case the sentences as
we thought that would ease the annotator’s task to detect some
sentiments and disambiguate acronyms. Besides these changes,
the preprocessing strategy is the same we described in the “data
selection” section.
To compare the annotations produced by the experts, we focused
on both the “type” assigned to the entity (ie, disease, drug, or
symptom) and also on the offsets for that entity. Taking that
into account, we decided to compute the results when using
relaxed constraints and strict constraints. In the case of using
relaxed constraints, we say that the entity annotated by both
annotators is a match if the type for the entity matches between
annotations and the spans of those annotations have some
overlap. In the case of using strict constraints, the match would
happen if the type in both annotations matches and the spans
for the annotated entities have the same offsets. Discontinuous
annotations were allowed and taken into account when
computing the matches, which means that in case of using strict
constraints, all the spans taking part on the entity’s annotation
should be the same.
We measured the level of agreement between the annotations
produced by our experts following the inter annotator agreement
(IAA) measure in the CLEF corpus [48]. This IAA metric is
reported to approximate the kappa score [48], and to be more
suited for this case [49]:
IAA=matches/(matches+nonmatches)
In our case matches accounts for the total number of token
matches for which both annotators agreed, and matches +
nonmatches counts all annotations performed by the annotator
being evaluated.
Results
Data Selection
Out of the 6000 selected sentences each for both Twitter and
PubMed that we extracted, we observed differing sample
frequencies of each drug. In both Twitter and PubMed, some
drugs attracted more attention than others, although in the case
of Twitter, temporal variability is a known fact [26] that has to
be taken into consideration.
We found that the frequency of the drugs in the extracted sample
had no correlation between Twitter and PubMed (Spearman
rho=.03), as shown in Table 2.
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Table 2. Total number of sentences for each drug name in Twitter and PubMed.
# Sentences in PubMed# TweetsDrug name
23969Bevacizumab
244363Buprenorphine
23974Carbamazepine
25081Ciprofloxacin
251331Citalopram
231344Cortisone
19373Destroamphetamine sulphate
24634Docetaxel
241242Duloxetine
238344Fluoxetine
20413Fluvoxamine maleate
242168Lamotrigine
84348Lisdexamfetamine
14756Lisinopril
2342Melphalan
112349Methylphenidate hydrochloride
10287Modafinil
23971Montelukast
248190Olanzapine
249365Paroxetine
249350Prednisone
247339Quetiapine
451Rupatadine
236343Sertraline
238122Tamoxifen
231133Topiramate
70206Trazodone
25314Triamcinolone acetonide
238326Venlafaxine
22662Ziprasidone
Selecting the Annotators
To evaluate the annotator’s performance, we used a gold
standard set of labels that we generated obtaining the majority
vote from the results we received from the 6 annotators and the
annotations produce by the first author of the paper, also giving
more weight to the pharmacists’ annotations in PubMed and to
social media users’ annotations in Twitter. That is, when there
were clear differences between the annotations provided by the
contributors with the higher weights and the rest of the
annotators, we took the former annotations into account.
As can be seen in Table 3, one pharmacist scored the best result,
87.5% agreement with the gold standard data (35 out of 40
sentences were correctly labelled).
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Table 3. Agreement with gold standard data during the annotator selection phase. We compared the results from 2 very active social media users, one
native English speaker and 3 pharmacists. We indicate between brackets the time it took to complete the annotation for that dataset (time in min).
Total (min)PubMed (min)Twitter (min)Annotator
0.75 (19)0.80 (10)0.70 (9)Social1
0.85 (15)0.70 (7)1.00 (8)Social2
0.67 (12)0.50 (6)0.85 (6)Native speaker
0.87 (15)0.85 (7)0.90 (8)Pharmacist1
0.75 (20)0.80 (9)0.70 (11)Pharmacist2
0.60 (30)0.70 (15)0.50 (15)Pharmacist3
Those results were in line with our expectations as social media
users got the best scores in social media texts, and the best scores
in PubMed texts were obtained by the pharmacists. However,
we were very surprised by the low scores obtained by
Pharmacist3 and the native English speaker. We followed up
with them discovering that Pharmacists3 had some trouble
understanding the samples because of those being written in
English language (it was also evidenced in the time it took her
to complete the task). In the case of the native English speaker,
he reported that he was not an active social media user and
requested further information on the set of tweets as he found
those texts to be hard to understand. Overall, we discovered the
native English speaker was too cautious when indicating which
sentences were positive cases as he annotated 7 sentences as
positive out of the 40 sentences (the gold standard data had 16
sentences tagged as positive sentences), whereas the rest of the
annotators indicated 13-18 sentences were positive (Pharmacist3,
who obtained the lowest score, was above that range as she
annotated 24 sentences as positive).
We decided to hire Pharmacists1 as she scored the best results,
and out of Social1, Social2, and Pharmacist2, we decided to
hire Pharmacist2 taking into account that the resulting corpus
would require annotation at entity level for which Pharmacist2’s
in-domain knowledge would be very valuable.
Annotation
Once the 2 pharmacists competed the annotation at sentence
level, we focused on the entity level annotation targeting at the
diseases, drugs, and symptoms. The results for Twitter and
PubMed are shown in Tables 4 and 5, using the relaxed
constraints and strict constraints strategy described in the
Methods section.
Table 4. Detail of annotations in Twitter. The first column shows the element being evaluated. Columns 2-5 show the inter annotator agreement scores
of pharmacist 1 (Ph1) and pharmacist 2 (Ph2) using relaxed and strict constraints. Columns 6 and 7 show the number of elements annotated by each
pharmacist. Columns 8 and 9 show the number of matching elements between pharmacist’s annotations using relaxed and strict constraints.
#Matches
(strict
constraints)
#Matches
(relaxed
constraints)
#Ph2#Ph1Ph2
(strict
constraints)
Ph1
(strict
constraints)
Ph2
(relaxed
constraints)
Ph1
(relaxed
constraints)
Annotated element
103910821096111194.8093.5298.7297.39Drug
21423625846482.9546.1291.4750.86Disease
6318991172116453.8454.2176.7177.23Symptom
34250366979551.1243.0275.1963.27Outcome-negative
9123010930.008.2640.0011.01Outcome-positive
37647078184248.1444.6660.1855.82Reason-to-use
9711512832487.5639.118.9646.37Duration
19578856421.593.3764.7710.11Exemplification
290333108958526.6349.5730.5856.92Modality
102912402118170948.5860.2158.5572.56Person
38541037136.8953.5252.4376.06Polarity
290345177347616.3660.9219.4672.48Sentiment
598643913413.4444.0319.5964.18Severity
249322145954217.0745.9422.0759.41Status
JMIR Public Health Surveill 2017 | vol. 3 | iss. 2 | e24 | p.7http://publichealth.jmir.org/2017/2/e24/
(page number not for citation purposes)
Alvaro et alJMIR PUBLIC HEALTH AND SURVEILLANCE
XSL•FO
RenderX
Table 5. Detail of annotations in PubMed. The first column shows the element being evaluated. Columns 2-5 show the inter annotator agreement scores
of pharmacist 1 (Ph1) and pharmacist 2 (Ph2) using relaxed and strict constraints. Columns 6 and 7 show the number of elements annotated by each
pharmacist. Columns 8 and 9 show the number of matching elements between pharmacist’s annotations using relaxed and strict constraints.
#Matches
(strict
constraints)
#Matches
(relaxed
constraints)
#Ph2#Ph1Ph2
(strict
constraints)
Ph1
(strict
constraints)
Ph2
(relaxed
constraints)
Ph1
(relaxed
constraints)
Annotated element
109612101236127188.6786.2397.9095.20Drug
580697732108679.2353.4195.2264.18Disease
39447578455850.2670.6160.5985.13Symptom
21826440743353.5650.3564.8660.97Outcome-negative
1418553225.4543.7532.7356.25Outcome-positive
7239651247153557.9847.1077.3962.87Reason-to-use
56606401158.7548.709.3852.17Duration
12431125.000.3250.000.64Exemplification
88510172013137043.9664.6050.5274.23Modality
8079201192143967.7056.0877.1863.93Person
44181622.2225.0022.2225.00Polarity
2315391.3122.221.9633.33Sentiment
1719574529.8237.7833.3342.22Severity
1414555262.5253.852.5253.85Status
By focusing on the results appearing in Tables 4 and 5, we see
that the agreement for the drugs in Twitter and PubMed is very
high, which was expected, given our sampling strategy, although
for diseases and symptoms the agreement score decreases
noticeably in both Twitter and PubMed.
When comparing the results for the relations (outcome-negative
, outcome-positive, and reason-to-use), we saw low levels of
agreement, having Twitter lower results in all cases. Analyzing
the number of annotations it was clear that the use of
outcome-positive relation varied considerably between
annotators, contributing to the low scores.
The attributes “person” (in PubMed), “modality” (in both
PubMed and Twitter), “polarity,” and “sentiment” (in Twitter)
were the ones obtaining the best scores. On the other hand, the
attribute “exemplification” (in both PubMed and Twitter),
“sentiment,” “polarity” (in PubMed), and “duration” (in Twitter)
were very prone to disagreements as these scores were the lowest
in Tables 4 and 5.
By analyzing the discrepancies in the annotations, we discovered
that the distinction between disease and symptom entities,
although theoretically clear, was hard to disambiguate in a
number of sentences. We can see that in the tweet “Is steroid
induced psychosis a thing? (Like short term prednisone tx)”
(see Figure 2), psychosis could be identified as a symptom
[50,51] or as a disease [52]. Similarly, the entity comorbid
obesity found in the PubMed sentence “The present case report
of topiramate’s effect on comorbid obesity,” could be also
understood as both a symptom and a disease [53]. Interestingly,
we observed in those examples that even if the chosen type of
entity (disease and symptom) was different, the annotators
agreed on the chosen CUI.
In the case of relations, we discovered that both
outcome-positive relation and reason-to-use relation were
confounded in some cases. One example from Twitter is the
sentence “How about trazodone, so I can just feel a little funny
and then knock out and have the best sleep of my life,” where
the drug, trazodone, and the symptom, the best sleep of my life,
were annotated as such by both annotators, although one
annotator indicated the relation between these entities was an
outcome-positive relation whereas the other annotator marked
it as a reason-to-use relation. The same observation was seen
in PubMed sentences as in “Because fatigue is a frequent
symptom of depression and there is some evidence that treatment
with an antidepressant improves fatigue in patients with
fibromyalgia, we hypothesized that the antidepressant
fluvoxamine might improve fatigue related to PBC and PSC.”
In this sentence, the drug (fluvoxamine) and the symptom
(fatigue) were correctly identified, same as the existing relation
between the entities, but the chosen type of relation was
different. This observation, combined with the fact that
outcome-positive relation was the least used type of relation,
helps in understanding the causes for the low inter annotator
agreement score.
Given the similarities between those concepts and the
disagreements that we detected, we evaluated the inter annotator
agreement score when conflating the concepts disease and
symptom under “disease or symptom” concept. We also grouped
together outcome-positive and reason-to-use relations under
“benefit” relation. The use of those categories produced a
noticeable improvement in the IAA scores. This strategy also
improved the agreement scores for most of the attributes as can
be seen in Table 6 (for Twitter), and Table 7 (for PubMed).
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Table 6. Detail of annotations in Twitter using the conflation strategy. The first column shows the element being evaluated. Columns 2-5 show the
inter annotator agreement scores of pharmacist 1 (Ph1) and pharmacist 2 (Ph2) using relaxed and strict constraints. Columns 6 and 7 show the number
of elements annotated by each pharmacist. Columns 8 and 9 show the number of matching elements between pharmacist's annotations using relaxed
and strict constraints.
#Matches
(strict
constraints)
#Matches
(relaxed
constraints)
#Ph2#Ph1Ph2
(strict
constraints)
Ph1
(strict
constraints)
Ph2
(relaxed
constraints)
Ph1
(relaxed
constraints)
Annotated element
103910821096111194.8093.5298.7297.39Drug
99913391430162869.8661.3693.6482.25Disease or symptom
36853566979555.0146.2979.9767.30Outcome-negative
49864881195161.4152.3779.9068.14Benefit
10412412832488.1141.949.6650.00Duration
19578856421.593.3764.7710.11Exemplification
319377108958529.2954.5334.6264.44Modality
109313212118170951.6163.9662.3777.30Person
41571037139.8157.7555.3480.28Polarity
298357177347616.8162.6120.1475.00Sentiment
639043913414.3547.0120.5067.16Severity
261335145954217.8948.1522.9661.81Status
Table 7. Detail of annotations in PubMed using the conflation strategy. The first column shows the element being evaluated. Columns 2-5 show the
inter annotator agreement scores of pharmacist 1 (Ph1) and pharmacist 2 (Ph2) using relaxed and strict constraints. Columns 6 and 7 show the number
of elements annotated by each pharmacist. Columns 8 and 9 show the number of matching elements between pharmacist’s annotations using relaxed
and strict constraints.
#Matches
(strict
constraints)
#Matches
(relaxed
constraints)
#Ph2#Ph1Ph2
(strict
constraints)
Ph1
(strict
constraints)
Ph2
(relaxed
constraints)
Ph1
(relaxed
constraints)
Annotated element
109612101236127188.6786.2397.9095.20Drug
122015111516164480.4774.2199.6791.91Disease or symptom
28535340743370.0265.8286.7381.52Outcome-negative
89112131302156768.4356.8693.1677.41Benefit
58626401159.0650.439.6953.91Duration
12431125.000.3250.000.64Exemplification
97811432013137048.5871.3956.7883.43Modality
89410301192143975.0062.1386.4171.58Person
77181638.8943.7538.8943.75Polarity
2315391.3122.221.9633.33Sentiment
2124574536.8446.6742.1153.33Severity
1414555262.5253.852.5253.85Status
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Figure 2. Sample with the annotation of a drug, a disease and the relation between these concepts in a sentence from Twitter.
Discussion
Principal Findings
We produced a corpus of documents obtained using a very
similar pipeline for both Twitter and PubMed. All the documents
were filtered and double annotated by the same experts
(pharmacists).
TwiMed corpus shows that the drugs appearing less often in
Twitter are those used to treat cancer (“docetaxel,”
“bevacizumab,” “tamoxifen”) and epilepsy (“topiramate,”
“carbamazepine”). On the other hand, the drugs used to treat
attention deficit hyperactivity disorder (“modafinil,”
“destroamphetamine sulphate,” “lisdexamfetamine”) are the
drugs having the most mentions in Twitter, whereas at the same
time those are the drugs having the least mentions in PubMed
sentences. This fact evidences that public concerns are not
always aligned with the interests of the scientific community,
and potential areas of research may emerge from those findings
to understand the reasons and related outcomes.
In our analysis, we observed a much higher balance for the drug
mentions in PubMed than in Twitter. Factors such as the
demographics of the user base in Twitter [54], or the time when
the messages were gathered [26] are elements that should be
studied in detail to measure their correlation with the different
distribution of drug mentions.
Given our main goal was to create a corpus covering mentions
of drugs used to treat a number of different conditions, we
applied a set of controlling mechanisms to extract the data from
Twitter and from PubMed, and researchers should be aware that
the drugs in this corpus have different distribution in the original
sources of information than the distributions presented here,
and following quantitative studies may be needed to understand
those differences.
We believe the reason for the high agreement in the annotation
of drugs is the use of a closed set of drug names that both
annotators knew beforehand. We can see, however, that there
is a lower level of agreement for the annotation of symptoms
and diseases and the main reason would be that the annotators
had to identify these mentions, and there is an open list of
entities that can be found in the texts, not to mention that these
entities could be presented using an exemplification. In addition,
in some contexts a disease can be considered as a symptom,
and the short nature of the sentences can act as a factor in
confounding the nature of these entities. Similarly, more
subjective concepts such as the duration attribute or the
exemplification attribute show a low level of agreement probably
because the annotators had to interpret these elements by
themselves and in some cases a certain level of subjectivity led
the decision.
Researchers should be aware that this corpus is not devised to
capture everything about the selected set of 30 drugs, and there
are a number of drug names appearing in the selected set of
sentences which were not annotated because these were not
included in the target set of drugs. Similarly, there are DDIs
and other relations that the corpus does not include because of
our constraints. However, we believe the provided sample can
help in training NLP systems to capture more information.
Nonetheless, we provide a set of semantically correct
annotations that can be used in NLP studies.
Our annotation also confirmed that there is lower agreement in
the annotation of tweets than in the annotation of PubMed
sentences, showing the noisy nature of Twitter [13]. Moreover,
when applying our conflation strategy aimed at resolving
disagreements, we observed that these differences still remained.
We noticed that a number of those disagreements were caused
when confounding “diseases” and “symptoms.” Similarly,
acronyms appearing in documents from PubMed tend to be
explained the first time they are presented, which does not
necessarily have to be when the drugs and related symptoms
and diseases are discussed. In our case we allowed the annotators
to access the full articles during the annotation process to reduce
the impact of this problem. Nonetheless, we believe the use of
acronyms is a potential source of confusion in texts where the
context is scarce, and this potential problem should be handled.
Additionally, other noticeable finding when using the same
guidelines is the fact that disagreements appear in similar
categories for both Twitter and PubMed. Figure 3 shows an
example where the string “eyelids are itchy” was annotated with
the duration of “regular” by one annotator (to indicate that there
is a continued lasting span), whereas the other annotator chose
“irregular” for the duration attribute (to indicate that there is no
pattern in the lasting span).
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Figure 3 also shows an example where the annotation for the
attribute “exemplification” differs between annotators as the
string “eyelids are itchy” was annotated as an exemplification
by only one of the two annotators.
Besides PubMed-Twitter comparative studies, our corpus is of
potential interest for researchers aiming at finding sentences
containing information on the drugs, symptoms, and diseases.
We believe this corpus can become a useful resource to discern
informational sentences in the area of pharmacovigilance as
other researchers can use the sentences we included in this
dataset to create classifiers targeting at the correct identification
of sentences reporting drug-use.
This dataset shows that for similar events coming from very
different data sources, the way in which people communicate
the same messages has noticeable differences. This corpus can
provide useful insights to science communicators and public
institutions for adapting their messages when addressing the
general public so that the information can attract more attention.
One of such examples would be the use of social media by
official health institutions, where most of the messages are more
formal than average social media messages, as a mean to reach
a wider audience during health promotion and disease prevention
campaigns as the wording may affect the impact of the
messages.
We believe combining the information contained in scientific
reports, of high quality and very trustworthy, together with the
information coming from social media messages, which is
global, has a high volume, and is up-to-date, should be taken
into account when building pharmacovigilance systems. We
hope this corpus can help researchers interested in combining
the potential of those data sources.
Figure 3. Sample of an annotation where “duration” and “exemplification” attributes are used.
Conclusions
We have presented a pharmacovigilance corpus that, to our
knowledge, is the first corpus that allows researchers to perform
direct comparative studies toward understanding the differences
between drug reports in Twitter and PubMed.
Our corpus contains annotations for drugs, symptoms, and
diseases; their attributes (polarity, person , modality,
exemplification, duration, severity, status, sentiment); and the
relations between the annotated entities (reason-to-use,
outcome-negative, and outcome-positive).
We also identified the source of a number of disagreements for
the annotated entities and relations, and proposed a conflation
strategy to resolve those discrepancies. That approach resulted
in higher agreement scores for most entities and relations.
We hope that given the comprehensive set of drug names and
the annotated entities and relations included in this corpus, it
can become a standard resource to compare results from
different pharmacovigilance studies, especially in the area of
NLP as it can help in training to recognize the entities and
relations in the texts. Similarly, this corpus can help in
comparing the performance of NLP tools across the 2 different
linguistic registers (formal and informal).
In summary, we present a comparable corpus for
pharmacovigilance studies and the annotation scheme we
devised. This work is presented to the research community in
the belief that such resources can help in this rapidly growing
area.
The corpus we release, available as Multimedia Appendix 1,
contains the annotations for all the entities, relations, and
attributes where both annotators agreed. Additionally, we
provide the tools to obtain the raw tweets used in the annotation,
to comply with Twitter’s terms of service [55], and we also
provide the tools to preprocess the raw sentences from both
Twitter and PubMed to reuse the released annotations.
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